Preview

Diagnostic radiology and radiotherapy

Advanced search
Fullscreen

For citations:


Krylov V.V., Legkodimova N.S., Kochetova T.Yu., Petriev V.M., Sigov M.A., Tishchenko V.K., Pronin A.I., Shurinov A.Yu., Petrosyan K.M., Spichenkova O.N., Karyakin O.B., Biryukov V.A., Stepanenko V.F., Vlasova O.P., Shegaj P.V., Ivanov S.A., Kaprin A.D. Radioligand therapy with 177Lu-DOTA-PSMA in metastatic castration-resistant prostate cancer. Pharmacokinetics, safety, antitumour efficacy. Diagnostic radiology and radiotherapy. 2022;13(4):75-85. (In Russ.) https://doi.org/10.22328/2079-5343-2022-13-4-75-85



Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2079-5343 (Print)